India's Top Brass Talks Of Repaying IP Debt, Equity For Academia, ESG Goals
National Research Foundation Approved
The heads of Sun, Cipla, Zydus, Lupin and Dr. Reddy's discuss moves to drive innovation including equity stakes for academia in research ventures as India approves an apex body to promote, fund and mentor research. Ways to progress ESG goals were also discussed at the IPA summit.
You may also be interested in...
The contentious issue of data exclusivity came to the fore during the European Free Trade Association's negotiations with India for a Free Trade Agreement. What are the arguments in support and against, including impact on compulsory and voluntary licensing?
FDA officials highlight at a recent summit in India recurring issues around drug manufacturing compliance including microbial contamination and data integrity concerns but emphasize that the agency isn’t in a “gotcha” mode for companies.
A B. cepacia contamination recurrence led the US FDA to double down on sterility assurance of water systems in 2022, a trend likely to continue, Part 7 of our series finds. Open cleanroom contamination continued to drive warning letters as Annex 1 policy revision adds incentives to separate workers from injectable drug products with access barriers or isolators.